Overexpression of the HER2 (Human egfr-related 2) transmembrane receptor, indenfied by immunohistochemistry or enhancement of the HER2/neu gene located on chromosome 17, is the trait of breast cancer or HER2-positive. This evidence concerns the gene ERBB2 and breast cancer.